C

Cryo-Cell International Inc
AMEX:CCEL

Watchlist Manager
Cryo-Cell International Inc
AMEX:CCEL
Watchlist
Price: 8.35 USD 0.6% Market Closed
Market Cap: 67.3m USD
Have any thoughts about
Cryo-Cell International Inc?
Write Note

Cryo-Cell International Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cryo-Cell International Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
C
Cryo-Cell International Inc
AMEX:CCEL
Current Portion of Long-Term Debt
$174.6k
CAGR 3-Years
-60%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Current Portion of Long-Term Debt
$296.3m
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
9%
Quest Diagnostics Inc
NYSE:DGX
Current Portion of Long-Term Debt
$603m
CAGR 3-Years
745%
CAGR 5-Years
-6%
CAGR 10-Years
39%
CVS Health Corp
NYSE:CVS
Current Portion of Long-Term Debt
$4.9B
CAGR 3-Years
47%
CAGR 5-Years
5%
CAGR 10-Years
24%
Cigna Corp
NYSE:CI
Current Portion of Long-Term Debt
$937m
CAGR 3-Years
244%
CAGR 5-Years
-23%
CAGR 10-Years
23%
Laboratory Corporation of America Holdings
NYSE:LH
Current Portion of Long-Term Debt
$1.4B
CAGR 3-Years
387%
CAGR 5-Years
23%
CAGR 10-Years
31%
No Stocks Found

Cryo-Cell International Inc
Glance View

Market Cap
67.3m USD
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

CCEL Intrinsic Value
5.83 USD
Overvaluation 30%
Intrinsic Value
Price
C

See Also

What is Cryo-Cell International Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
174.6k USD

Based on the financial report for Aug 31, 2024, Cryo-Cell International Inc's Current Portion of Long-Term Debt amounts to 174.6k USD.

What is Cryo-Cell International Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-44%

Over the last year, the Current Portion of Long-Term Debt growth was 7%. The average annual Current Portion of Long-Term Debt growth rates for Cryo-Cell International Inc have been -60% over the past three years , -44% over the past five years .

Back to Top